Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-Menopausal Osteoporosis”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00532246
What this trial is testing

Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

Who this might be right for
Osteoporosis, Post-Menopausal
Eli Lilly and Company 147
Post-approval studies (Phase 4)Study completedNCT00130403
What this trial is testing

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

Who this might be right for
Osteoporosis, Postmenopausal
Sanofi 290
Early research (Phase 1)Study completedNCT01074723
What this trial is testing

B-cryptoxanthin and Phytosterols on Bone Remodeling and Cardiovascular Risk Factors

Who this might be right for
Postmenopausal Disorder
Puerta de Hierro University Hospital 36
Not applicableUnknownNCT01854086
What this trial is testing

Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday

Who this might be right for
Osteoporosis
Meir Medical Center 150
Post-approval studies (Phase 4)Study completedNCT02499237
What this trial is testing

Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation

Who this might be right for
Postmenopausal Osteoporosis
424 General Military Hospital 57
Not applicableStudy completedNCT00891553
What this trial is testing

CR9112792, a Follow-up of Study CR9108963

Who this might be right for
Osteoporosis
GlaxoSmithKline 171
Large-scale testing (Phase 3)Study completedNCT01806792
What this trial is testing

Post-menopausal Women Osteoporosis(Phase III)

Who this might be right for
Postmenopausal Women Osteoporosis
Hanlim Pharm. Co., Ltd. 150
Not applicableStudy completedNCT00787904
What this trial is testing

Role of T-cells in Post-Menopausal Osteoporosis

Who this might be right for
Osteoporosis
Atlanta VA Medical Center 19
Not applicableStudy completedNCT02422069
What this trial is testing

Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan

Who this might be right for
Postmenopausal Osteoporosis
Hoffmann-La Roche 624
Not applicableWithdrawnNCT07148479
What this trial is testing

Telerehabilitation Versus Traditional Balance Training in Women With Osteoporosis.

Who this might be right for
Osteoporosis Postmenopausal
Riphah International University
Post-approval studies (Phase 4)Study completedNCT00545090
What this trial is testing

ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

Who this might be right for
Post Menopausal Osteoporosis
Hoffmann-La Roche 561
Testing effectiveness (Phase 2)Study completedNCT00293813
What this trial is testing

A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density

Who this might be right for
Postmenopausal Osteoporosis
Amgen 247
Large-scale testing (Phase 3)Study completedNCT01249261
What this trial is testing

Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover

Who this might be right for
Postmenopausal Women With Osteoporosis
Warner Chilcott 61
Post-approval studies (Phase 4)Not Yet RecruitingNCT06720350
What this trial is testing

Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures

Who this might be right for
Osteoporosis in Post-menopausal Women
Marmara University 60
Post-approval studies (Phase 4)Study completedNCT00431444
What this trial is testing

Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density

Who this might be right for
Osteoporosis
Novartis 110
Not applicableStudy completedNCT01416194
What this trial is testing

Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)

Who this might be right for
Osteoporosis, Postmenopausal
Pfizer 10,497
Testing effectiveness (Phase 2)WithdrawnNCT06973109
What this trial is testing

Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes

Who this might be right for
Osteoporosis, Post-menopausal
University of Pittsburgh
Not applicableStudy completedNCT03503552
What this trial is testing

Body Composition and Risk for Development of Pre-diabetes in Post-menopausal Chinese Women in Singapore

Who this might be right for
OsteoporosisMetabolic Syndrome
JeyaKumar Henry 97
Testing effectiveness (Phase 2)Study completedNCT00409032
What this trial is testing

A Dose-response Study With Strontium Malonate in Postmenopausal Women

Who this might be right for
Osteoporosis
Osteologix 275
Post-approval studies (Phase 4)Study completedNCT00453492
What this trial is testing

Risedronate Sodium in Post Menopausal Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Sanofi 246
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation